🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Bluecopa raises $1.8 Mn in pre-Series A round

EntrackrEntrackr · 1y ago
Bluecopa raises $1.8 Mn in pre-Series A round
Medial

Finance operations (FinOps) automation platform Bluecopa has raised $1.8 million in a pre-Series A funding round co-led by Blume Ventures, Dallas Venture Capital, and Venture Catalysts. The proceeds will be utilized to expand market reach, enhance AI capabilities, and advance product development, Bluecopa said in a press release. Co-founded in 2021 by Nilotpal Chanda, Raghavendra Reddy, and Satya Prakash Buddhavarapu, Bluecopa leverages AI and data analytics to enable the office of the CFO to drive efficiency through autonomous financial processes. It offers a comprehensive solution for modern finance teams and its cloud-native platform, powered by AI, provides a unified solution for finance teams, streamlining operations and improving efficiency. According to market research, the global market of FinOps is more than $40 billion. Bluecopa claims that its solution provides value to finance leaders from major industries like eCommerce, financial services, travel, logistics, and gaming. The company has added several prominent customers in the last 12 months.

Related News

ErlySign raises $1.8 Mn in pre-Series A round from Ashish Kacholia

EntrackrEntrackr · 10m ago
ErlySign raises $1.8 Mn in pre-Series A round from Ashish Kacholia
Medial

ErlySign raises $1.8 Mn in pre-Series A round from Ashish Kacholia Healthtech startup ErlySign has raised Rs 16 crore ($1.8 million) in its pre-Series A round from Ashish Kacholia. The proceeds will be used in clinical trials, securing CDSCO (Central Drugs Standard Control Organisation) approvals, and bringing ErlySign’s oral cancer detection kit to market. Founded in 2019 by Shubhendra Singh Thakur and Deovrat Begde, ErlySign develops solutions for early detection of oral cancer. The startup also claims to offer India’s first salivary biomarker-based test which can identify pre-cancerous conditions much before visible symptoms emerge. Looking ahead, ErlySign plans to use CRISPR miRNA-based testing technology to detect multiple types of cancer using the same saliva sample within 15–20 minutes.

Exclusive: Bluecopa kicks off Series A with a 2.3X valuation surge

EntrackrEntrackr · 19d ago
Exclusive: Bluecopa kicks off Series A with a 2.3X valuation surge
Medial

url: https://entrackr.com/exclusive/exclusive-bluecopa-kicks-off-series-a-with-a-23x-valuation-surge-10788821. Content: FinOps automation platform Bluecopa to begin its Series A round with a Rs 64.7 crore (around $7.35 million) fundraise led by Valorshield Pte Ltd (Analog), with participation from existing investors Blume Ventures and Dallas Venture Capital. This investment follows the company’s $1.8 million pre-Series A round secured in September last year. The Bluecopa’s board has issued 4,562 Series A compulsory convertible preference shares at an issue price of Rs 1,41,849.13 per share to raise the above-mentioned amount, according to its filing with the Registrar of Companies (RoC). Valorshield Pte Ltd led (Analog) the round with Rs 38.8 crore ($4.4 million) investment, while the existing investors Blume Ventures and Dallas Venture Capital participated with Rs 12.93 crore each. According to Entrackr’s analysis, Bluecopa’s valuation surged 2.3X to Rs 306 crore or approximately $35 million post money, compared to Rs 133 crore valuation in its previous $1.8 million round. Co-founded in 2021 by Nilotpal Chanda, Raghavendra Reddy, and Satya Prakash Buddhavarapu, Bluecopa uses AI and data analytics to help CFOs automate and optimize financial operations. Its cloud-native platform offers a unified system for modern finance teams, enabling autonomous processes that streamline workflows and improve overall efficiency. According to startup data intelligence platform TheKredible, the Hyderabad-based company has raised around over $11 million to date including its seed round of $2.3 million raised in August 2022. Financially, for the fiscal year ended March 2024, the Blume-backed company reported operating revenue of just Rs 5.2 lakh and non-operating income of Rs 27.38 lakh. It posted a net loss of Rs 7.2 crore during the period. The company has yet to disclose its FY25 financials.

Ice cream brand Go Zero raises $1.5 Mn

EntrackrEntrackr · 1y ago
Ice cream brand Go Zero raises $1.5 Mn
Medial

Ice cream brand Go Zero has raised $1.5 million in its follow-on pre-Series A funding round from DSG Consumer Partners, Saama, and V3 Ventures, among others. The round also saw participation from notable angel investors such as Arjun Purkayastha. Earlier in August last year, the startup had raised $1 million in its pre-Series A funding round led by DSG Consumer Partners, Saama, and V3 Ventures. Founded by Kiran Shah, Go Zero has a diversified product portfolio featuring low-calorie, high-protein, and vegan ice creams. The startup claims that all its products are sweetened with plant-based sweeteners, which are low in calories. Currently present in 16 cities and over 125 dark stores, Go Zero ice cream brand is available on both quick commerce and e-commerce platforms in less than two years of launch. In FY24, Go Zero claims to have grown 4X compared to FY23 and while it saw 7X growth on quick commerce in just 5 months this summer. Go Zero competes with Hocco and NIC. Last year, NIC had raised $11 million in a growth funding round led by Jungle Ventures whereas Hocco recently raised $12 million from Chona family and others.

Download the medial app to read full posts, comements and news.